Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue.
394
Zitationen
9
Autoren
2000
Jahr
Abstract
An enhancing lesion with a normalized rCBV ratio higher than 2.6 or lower than 0.6 may suggest tumor recurrence or nonneoplastic contrast-enhancing tissue, respectively. In these cases, further examination with 201Tl-SPECT may not be necessary. However, when the normalized rCBV ratio is between 0.6 and 2.6, 201Tl-SPECT may be useful in making the differentiation.
Ähnliche Arbeiten
Advances in functional and structural MR image analysis and implementation as FSL
2004 · 14.039 Zit.
A default mode of brain function
2001 · 12.343 Zit.
FSL
2011 · 11.670 Zit.
Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images
2002 · 10.610 Zit.
Functional connectivity in the motor cortex of resting human brain using echo‐planar mri
1995 · 10.031 Zit.